Background & aims: Auricular neurostimulation therapy, in which a noninvasive device delivers percutaneous electrical nerve field stimulation (PENFS) to the external ear, is effective in pediatric patients with functional abdominal pain disorders. Preclinical studies showed that PENFS modulates central pain pathways and attenuates visceral hyperalgesia. We evaluated the efficacy of PENFS in adolescents with irritable bowel syndrome (IBS).
Methods: We analyzed data from pediatric patients with IBS who participated in a double-blind trial at a tertiary care gastroenterology clinic from June 2015 through November 2016. Patients were randomly assigned to groups that received PENFS (n = 27; median age, 15.3 y; 24 female) or a sham stimulation (n = 23; median age, 15.6 y; 21 female), 5 days/week for 4 weeks. The primary endpoint was number of patients with a reduction of 30% or more in worst abdominal pain severity after 3 weeks. Secondary endpoints were reduction in composite abdominal pain severity score, reduction in usual abdominal pain severity, and improvement in global symptom based on a symptom response scale (-7 to +7; 0 = no change) after 3 weeks.
Results: Reductions of 30% or more in worst abdominal pain were observed in 59% of patients who received PENFS vs 26% of patients who received the sham stimulation (P = .024). The patients who received PENFS had a composite pain median score of 7.5 (interquartile range [IQR], 3.6-14.4) vs 14.4 for the sham group (IQR, 4.5-39.2) (P = .026) and a usual pain median score of 3.0 (IQR, 3.0-5.0) vs 5.0 in the sham group (IQR, 3.0-7.0) (P = .029). A symptom response scale score of 2 or more was observed in 82% of patients who received PENFS vs 26% of patients in the sham group (P ≤ .001). No significant side effects were reported.
Conclusions: Auricular neurostimulation reduces abdominal pain scores and improves overall wellbeing in adolescents with IBS. PENFS is a noninvasive treatment option for pediatric patients with functional bowel disorders. ClinicalTrials.gov no: NCT02367729.
Keywords: Controlled; FAPDs; Neuromodulation; PENFS.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Neurostimulation for Abdominal Pain-Related Functional Gastrointestinal Disorders in Adolescents: A Randomised, Double-Blind, Sham-Controlled TrialK Kovacic et al. Lancet Gastroenterol Hepatol 2 (10), 727-737. PMID 28826627. - Randomized Controlled TrialAmerican Neurogastroenterology and Motility Society.
Functional Magnetic Resonance Imaging Evaluation of Auricular Percutaneous Electrical Neural Field Stimulation for Fibromyalgia: Protocol for a Feasibility StudyM Gebre et al. JMIR Res Protoc 7 (2), e39. PMID 29410385.This is a feasibility study that is meant to demonstrate the practicality of using fcMRI to study the neural correlates of PENFS outcomes and provide information regardin …
Percutaneous Electrical Nerve Field Stimulation Modulates Central Pain Pathways and Attenuates Post-Inflammatory Visceral and Somatic Hyperalgesia in RatsR Babygirija et al. Neuroscience 356, 11-21. PMID 28526575.A non-invasive, auricular percutaneous electrical nerve field stimulation (PENFS) has been suggested to modulate central pain pathways. We investigated the effects of BRI …
Biofeedback for Treatment of Irritable Bowel SyndromeJZ Goldenberg et al. Cochrane Database Syst Rev 2019 (11). PMID 31713856. - ReviewThere is currently not enough evidence to assess whether biofeedback interventions are effective for controlling symptoms of IBS. Given the positive results reported in s …
Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and EluxadolineA Rivkin et al. Pharmacotherapy 36 (3), 300-16. PMID 26971716. - ReviewDiarrhea-predominant irritable bowel syndrome (IBS-D) is one of the most common diagnoses made by gastroenterologists. Current pharmacologic treatments for IBS-D include …